vs

Side-by-side financial comparison of Abbott Laboratories (ABT) and Cisco (CSCO). Click either name above to swap in a different company.

Cisco is the larger business by last-quarter revenue ($15.3B vs $11.5B, roughly 1.3× Abbott Laboratories). Cisco runs the higher net margin — 20.7% vs 15.5%, a 5.2% gap on every dollar of revenue. On growth, Cisco posted the faster year-over-year revenue change (9.7% vs 4.4%). Abbott Laboratories produced more free cash flow last quarter ($2.6B vs $1.5B). Over the past eight quarters, Cisco's revenue compounded faster (9.9% CAGR vs 7.2%).

Abbott Laboratories, commonly known as Abbott, is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois. The company produces pharmaceuticals for sale outside the United States, diagnostic products, nutritional products, and medical devices.

Cisco Systems, Inc. is an American multinational digital communications technology conglomerate corporation headquartered in San Jose, California. Cisco develops, manufactures, and sells networking hardware, software, telecommunications equipment and other high-technology services and products.

ABT vs CSCO — Head-to-Head

Bigger by revenue
CSCO
CSCO
1.3× larger
CSCO
$15.3B
$11.5B
ABT
Growing faster (revenue YoY)
CSCO
CSCO
+5.3% gap
CSCO
9.7%
4.4%
ABT
Higher net margin
CSCO
CSCO
5.2% more per $
CSCO
20.7%
15.5%
ABT
More free cash flow
ABT
ABT
$1.1B more FCF
ABT
$2.6B
$1.5B
CSCO
Faster 2-yr revenue CAGR
CSCO
CSCO
Annualised
CSCO
9.9%
7.2%
ABT

Income Statement — Q4 FY2025 vs Q2 FY2026

Metric
ABT
ABT
CSCO
CSCO
Revenue
$11.5B
$15.3B
Net Profit
$1.8B
$3.2B
Gross Margin
57.0%
65.0%
Operating Margin
19.6%
24.6%
Net Margin
15.5%
20.7%
Revenue YoY
4.4%
9.7%
Net Profit YoY
-80.8%
30.8%
EPS (diluted)
$1.01
$0.80

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ABT
ABT
CSCO
CSCO
Q1 26
$15.3B
Q4 25
$11.5B
$14.9B
Q3 25
$11.4B
$14.7B
Q2 25
$11.1B
$14.1B
Q1 25
$10.4B
$14.0B
Q4 24
$11.0B
$13.8B
Q3 24
$10.6B
$13.6B
Q2 24
$10.4B
$12.7B
Net Profit
ABT
ABT
CSCO
CSCO
Q1 26
$3.2B
Q4 25
$1.8B
$2.9B
Q3 25
$1.6B
$2.5B
Q2 25
$1.8B
$2.5B
Q1 25
$1.3B
$2.4B
Q4 24
$9.2B
$2.7B
Q3 24
$1.6B
$2.2B
Q2 24
$1.3B
$1.9B
Gross Margin
ABT
ABT
CSCO
CSCO
Q1 26
65.0%
Q4 25
57.0%
65.5%
Q3 25
55.4%
63.2%
Q2 25
56.4%
65.6%
Q1 25
56.9%
65.1%
Q4 24
55.0%
65.9%
Q3 24
55.8%
64.4%
Q2 24
55.6%
65.1%
Operating Margin
ABT
ABT
CSCO
CSCO
Q1 26
24.6%
Q4 25
19.6%
22.6%
Q3 25
18.1%
21.0%
Q2 25
18.4%
22.6%
Q1 25
16.3%
22.3%
Q4 24
17.4%
17.0%
Q3 24
17.5%
19.2%
Q2 24
16.1%
17.2%
Net Margin
ABT
ABT
CSCO
CSCO
Q1 26
20.7%
Q4 25
15.5%
19.2%
Q3 25
14.5%
17.4%
Q2 25
16.0%
17.6%
Q1 25
12.8%
17.4%
Q4 24
84.1%
19.6%
Q3 24
15.5%
15.8%
Q2 24
12.5%
14.8%
EPS (diluted)
ABT
ABT
CSCO
CSCO
Q1 26
$0.80
Q4 25
$1.01
$0.72
Q3 25
$0.94
$0.64
Q2 25
$1.01
$0.62
Q1 25
$0.76
$0.61
Q4 24
$5.26
$0.68
Q3 24
$0.94
$0.54
Q2 24
$0.74
$0.46

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ABT
ABT
CSCO
CSCO
Cash + ST InvestmentsLiquidity on hand
$8.9B
$15.8B
Total DebtLower is stronger
$12.9B
$24.6B
Stockholders' EquityBook value
$52.1B
$47.7B
Total Assets
$86.7B
$123.4B
Debt / EquityLower = less leverage
0.25×
0.52×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ABT
ABT
CSCO
CSCO
Q1 26
$15.8B
Q4 25
$8.9B
$15.7B
Q3 25
$7.7B
$16.1B
Q2 25
$7.3B
$15.6B
Q1 25
$6.8B
$16.9B
Q4 24
$8.0B
$18.7B
Q3 24
$7.8B
$17.9B
Q2 24
$7.2B
$18.8B
Total Debt
ABT
ABT
CSCO
CSCO
Q1 26
$24.6B
Q4 25
$12.9B
$24.6B
Q3 25
$24.6B
Q2 25
$25.1B
Q1 25
$20.1B
Q4 24
$14.1B
$20.1B
Q3 24
$20.1B
Q2 24
$20.1B
Stockholders' Equity
ABT
ABT
CSCO
CSCO
Q1 26
$47.7B
Q4 25
$52.1B
$46.9B
Q3 25
$51.0B
$46.8B
Q2 25
$50.6B
$45.9B
Q1 25
$48.8B
$45.5B
Q4 24
$47.7B
$45.3B
Q3 24
$39.8B
$45.5B
Q2 24
$39.3B
$45.8B
Total Assets
ABT
ABT
CSCO
CSCO
Q1 26
$123.4B
Q4 25
$86.7B
$121.1B
Q3 25
$84.2B
$122.3B
Q2 25
$84.0B
$119.8B
Q1 25
$81.4B
$121.4B
Q4 24
$81.4B
$123.3B
Q3 24
$74.4B
$124.4B
Q2 24
$73.0B
$123.0B
Debt / Equity
ABT
ABT
CSCO
CSCO
Q1 26
0.52×
Q4 25
0.25×
0.53×
Q3 25
0.53×
Q2 25
0.55×
Q1 25
0.44×
Q4 24
0.30×
0.44×
Q3 24
0.44×
Q2 24
0.44×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ABT
ABT
CSCO
CSCO
Operating Cash FlowLast quarter
$3.3B
$1.8B
Free Cash FlowOCF − Capex
$2.6B
$1.5B
FCF MarginFCF / Revenue
22.9%
10.0%
Capex IntensityCapex / Revenue
6.0%
1.8%
Cash ConversionOCF / Net Profit
1.87×
0.57×
TTM Free Cash FlowTrailing 4 quarters
$7.4B
$12.2B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ABT
ABT
CSCO
CSCO
Q1 26
$1.8B
Q4 25
$3.3B
$3.2B
Q3 25
$2.8B
$4.2B
Q2 25
$2.0B
$4.1B
Q1 25
$1.4B
$2.2B
Q4 24
$2.9B
$3.7B
Q3 24
$2.7B
$3.7B
Q2 24
$2.0B
$4.0B
Free Cash Flow
ABT
ABT
CSCO
CSCO
Q1 26
$1.5B
Q4 25
$2.6B
$2.9B
Q3 25
$2.3B
$4.0B
Q2 25
$1.5B
$3.8B
Q1 25
$933.0M
$2.0B
Q4 24
$2.1B
$3.4B
Q3 24
$2.1B
$3.5B
Q2 24
$1.4B
$3.8B
FCF Margin
ABT
ABT
CSCO
CSCO
Q1 26
10.0%
Q4 25
22.9%
19.4%
Q3 25
20.2%
27.4%
Q2 25
13.9%
26.8%
Q1 25
9.0%
14.5%
Q4 24
19.6%
24.9%
Q3 24
20.2%
25.9%
Q2 24
13.8%
29.9%
Capex Intensity
ABT
ABT
CSCO
CSCO
Q1 26
1.8%
Q4 25
6.0%
2.2%
Q3 25
4.4%
1.5%
Q2 25
4.5%
1.8%
Q1 25
4.7%
1.5%
Q4 24
6.6%
1.6%
Q3 24
5.2%
1.5%
Q2 24
5.1%
1.3%
Cash Conversion
ABT
ABT
CSCO
CSCO
Q1 26
0.57×
Q4 25
1.87×
1.12×
Q3 25
1.70×
1.66×
Q2 25
1.15×
1.63×
Q1 25
1.07×
0.92×
Q4 24
0.31×
1.35×
Q3 24
1.64×
1.73×
Q2 24
1.51×
2.11×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ABT
ABT

Segment breakdown not available.

CSCO
CSCO

Networking$8.3B54%
Services$3.7B24%
Security$2.0B13%
Collaboration$1.1B7%
Observability$277.0M2%

Related Comparisons